Recro Pharma Cash Conversion Cycle 2011-2026 | REPH

Annual Cash Conversion Cycle Recro Pharma

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
105	99	105	145	186	138	67.2	100	157	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
186	67.2	123

Quarterly Cash Conversion Cycle Recro Pharma

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
102	112	109	-	106	96.8	97.8	-	116	115	112	-	119	130	109	-	169	133	121	-	131	101	87.8	-	76.6	68.7	77.2	-	129	99.1	102	-	115	114	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
169	68.7	110

Cash Conversion Cycle of other stocks in the Drug manufacturers industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	-38	-	7.5 %	$ 6.35 M	USA
Alimera Sciences ALIM	-128	-	-	$ 142 M	USA
Aerie Pharmaceuticals AERI	460	-	-	$ 754 M	USA
Agile Therapeutics AGRX	-206	-	10.11 %	$ 58.2 M	USA
Adamis Pharmaceuticals Corporation ADMP	-224	-	0.86 %	$ 117 M	USA
Aurora Cannabis ACB	1.45 K	$ 3.3	-0.3 %	$ 86.3 M	Canada
China Pharma Holdings CPHI	164	$ 0.63	-	$ 11 M	China
Catalent CTLT	110	-	-	$ 11.5 B	USA
Athenex ATNX	137	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	192	-	-	$ 2.06 B	France
Cronos Group CRON	213	$ 2.55	1.19 %	$ 1.32 B	Canada
DURECT Corporation DRRX	41.4	-	-	$ 50.1 M	USA
Emergent BioSolutions EBS	181	$ 8.04	-0.12 %	$ 412 M	USA
Endo International plc ENDP	141	-	-	$ 28.9 M	Irlanda
Evoke Pharma EVOK	45.7	-	-	$ 36.6 M	USA
HEXO Corp. HEXO	775	-	2.45 %	$ 38.1 M	Canada
Cumberland Pharmaceuticals CPIX	-161	$ 3.18	4.1 %	$ 44.7 M	USA
Pacira BioSciences PCRX	209	$ 22.82	0.75 %	$ 1.06 B	USA
Bausch Health Companies BHC	78.9	$ 4.97	-2.55 %	$ 1.81 B	Canada
Harrow Health HROW	18.3	$ 35.03	3.03 %	$ 1.29 B	USA
OptiNose OPTN	314	-	-	$ 1.08 B	USA
Evolus EOLS	74.8	$ 4.43	-5.45 %	$ 286 M	USA
Rockwell Medical RMTI	45	$ 1.04	1.96 %	$ 24.3 M	USA
SCYNEXIS SCYX	106	$ 0.87	-0.29 %	$ 43.4 M	USA
Eagle Pharmaceuticals EGRX	139	-	-39.89 %	$ 27.7 M	USA
Sonoma Pharmaceuticals SNOA	150	$ 2.34	-8.24 %	$ 2.9 M	USA
OrganiGram Holdings OGI	2.92 K	$ 1.36	0.01 %	$ 402 M	Canada
PetIQ PETQ	53.8	-	1.64 %	$ 400 M	USA
Tilray TLRY	169	$ 6.57	1.86 %	$ 4.06 B	Canada
PLx Pharma PLXP	111	-	-27.8 %	$ 2.56 M	USA
ProPhase Labs PRPH	96	-	-	$ 5.07 M	USA
Jupiter Wellness JUPW	-21.1	-	-	$ 33.6 M	USA
TherapeuticsMD TXMD	-723	$ 2.28	-1.2 %	$ 23.8 M	USA
Radius Health RDUS	-53.5	-	-	$ 1.42 B	USA
Veru VERU	6.7	$ 2.28	-0.87 %	$ 308 M	USA
Viatris VTRS	155	$ 13.43	1.02 %	$ 16.1 B	USA
Lannett Company LCI	173	-	1.15 %	$ 7.11 M	USA
cbdMD YCBD	92	$ 0.78	1.3 %	$ 3.36 M	USA
Organogenesis Holdings ORGO	64.5	$ 2.43	-1.62 %	$ 320 M	USA
Perrigo Company plc PRGO	137	$ 9.65	0.89 %	$ 1.34 B	USA
Canopy Growth Corporation CGC	177	$ 0.94	-2.32 %	$ 101 M	Canada
Assertio Holdings ASRT	467	$ 15.95	13.93 %	$ 102 M	USA